NSTEMI Clinical Trial
Official title:
The Efficacy of Oral Ivabradine in Patients Presenting With Acute Non ST-segment Elevation Myocardial Infarction (NSTEMI): Interventional Randomized Parallel Study
This study aims to evaluate the beneficial effect of heart rate reduction of oral ivabradine
in patients presenting with non ST-segment elevation myocardial infarction (NSTEMI) during
acute stage post percutaneous coronary intervention versus conventional treatment.
Materials and methods: A total of 100 patients admitted to the emergency department, National
Heart Institute, Cairo, Egypt were randomized into two groups as follows: Group A: 50
patients with NSTEMI treated with ivabradine (5mg twice daily) in addition to the
conventional treatment; Group B: 50 patients with NSTEMI treated with the conventional
treatment only. Demographic data, detailed history, clinical examination, chest pain onset,
blood pressure, heart rate (HR), temperature and respiratory rate, electrocardiogram (ECG) as
well as echocardiography and laboratory investigations were recorded. Patients were monitored
for a period of 3-5 days (acute stage).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Recruiting |
NCT02748603 -
Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease
|
N/A | |
Active, not recruiting |
NCT01433627 -
Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX
|
Phase 3 | |
Completed |
NCT01197742 -
Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction
|
N/A | |
Completed |
NCT01634425 -
Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT)
|
Phase 4 | |
Not yet recruiting |
NCT00774475 -
Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
|
Phase 3 | |
Active, not recruiting |
NCT04900155 -
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
|
N/A | |
Completed |
NCT04490928 -
The Problem of Incomplete Myocardial Revascularization in Percutaneous Coronary Intervention in Patients With NSTEMI
|
||
Completed |
NCT04861519 -
Pivotal, Single-arm Clinical Trial to Assess the Efficacy and Safety of the MedHub AutocathFFR Software Device
|
||
Not yet recruiting |
NCT06404515 -
Telehealth Group Counseling and Preventive Care for Women
|
N/A | |
Not yet recruiting |
NCT05263778 -
Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
|
Phase 4 | |
Withdrawn |
NCT02095522 -
COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients
|
N/A | |
Recruiting |
NCT05764057 -
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
|
Phase 3 | |
Enrolling by invitation |
NCT05800951 -
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
|
||
Completed |
NCT01159366 -
Incidence of Occluded Culprit Arteries and Impact of Coronary Collaterals on Outcome in Patients With NSTEMI
|
Phase 4 | |
Completed |
NCT04270630 -
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
|
N/A | |
Withdrawn |
NCT05957172 -
Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
|
||
Completed |
NCT01543373 -
Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS
|
N/A | |
Active, not recruiting |
NCT05175261 -
Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
|
||
Recruiting |
NCT04824001 -
Exercise Echocardiography on LV Mechanics in Patients With CAD: a Speckle-tracking Echocardiography
|